Analyst firms · H.C. Wainwright · AADI
H.C. Wainwright AADI price target and rating history
Aadi Bioscience Inc. (AADI) · Health Care
H.C. Wainwright rates Aadi Bioscience Inc. (AADI) Neutral with a $49 price target, as of its latest action on Dec 15, 2023. It has published 3 rating actions on AADI since August 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $49
- Median target, all firms
- Too few
- Actions on AADI
- 3
H.C. Wainwright price target on AADI
Every H.C. Wainwright rating on AADI
- Dec 15, 2023
- Nov 24, 2021
- Aug 30, 2021
Questions about H.C. Wainwright and AADI
- What is H.C. Wainwright's price target for AADI?
- H.C. Wainwright's latest stated price target for Aadi Bioscience Inc. (AADI) is $49, from its action on Nov 24, 2021.
- What is H.C. Wainwright's rating on AADI?
- H.C. Wainwright rates AADI Neutral, a neutral rating, as of Dec 15, 2023.
- When did H.C. Wainwright last change its view on AADI?
- On Dec 15, 2023, H.C. Wainwright downgrades to Neutral from Buy.
All H.C. Wainwright ratingsAADI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.